Package Leaflet: Information for the User
Geloprofen 400 mg film-coated tablets
ibuprofen
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the package leaflet
Geloprofen contains ibuprofen as the active substance and belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
This medicine is used in adults and adolescents over 12 years old (weight over 40 kg) for the symptomatic relief of occasional mild or moderate pain, such as headache, dental, menstrual, muscular (cramps) or back (lumbago) pain, and in febrile conditions.
Do not take Geloprofen
swelling of the face, lips or tongue, nasal discharge, difficulty breathing or asthma.
to use anticoagulant medications at the same time, your doctor will perform blood coagulation tests.
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medicine:
2 of 10
It is important to use the smallest dose that relieves-controls the pain and not to take this medicine for longer than necessary to control your symptoms.
Skin reactions
Severe skin reactions have been reported with this medicine. Stop taking this medicine and consult your doctor immediately if you experience any skin rash, lesions on the mucous membranes, blisters, or other signs of allergy, as these may be the first signs of a very severe skin reaction. See section 4.
Cardiovascular precautions
Anti-inflammatory/analgesic medications like ibuprofen may be associated with a small increased risk of heart attack or stroke, especially when used in high doses. Do not exceed the recommended dose or treatment duration.
You should discuss your treatment with your doctor or pharmacist before taking this medicine if:
Children and adolescents
There is a risk of kidney damage and dehydrated adolescents
Precautions during pregnancy and in women of childbearing age
Since the administration of ibuprofen-type medications has been associated with an increased risk of congenital anomalies/abortions, it is not recommended to administer it during the first and second trimester of pregnancy unless it is strictly necessary. In these cases, the dose and duration will be limited to the minimum possible.
In the third trimester, the administration of this medicine is contraindicated.
For women of childbearing age, it should be taken into account that ibuprofen-type medications have been associated with a decrease in fertility.
Infections
This medicine may hide the signs of an infection, such as fever and pain. Consequently, ibuprofen may delay the appropriate treatment of the infection, which may increase the risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and the symptoms of the infection persist or worsen, consult a doctor without delay.
3 of 10
Other medicines and Geloprofen
Inform your doctor or pharmacist if you are taking, have recently taken, or may take any other medicine.
This medicine may affect or be affected by other medicines. For example:
4 of 10
Other medicines may also affect or be affected by treatment with ibuprofen. Therefore, you should always consult your doctor or pharmacist before using ibuprofene with other medicines.
The use of ibuprofen may alter the following laboratory tests:
Inform your doctor if you are going to undergo a clinical analysis and are taking or have recently taken ibuprofen.
Taking Geloprofen with food, drinks, and alcohol
It is recommended to take this medicine with milk or with food, or immediately after eating, to reduce the possibility of stomach upset. Do not drink alcohol, as it may increase gastrointestinal side effects.
Pregnancy, breastfeeding, and fertility
The use of this medicine is not recommended in women who are trying to become pregnant. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Ibuprofen should not be taken during pregnancy, especially during the third trimester (see section precautions during pregnancy and in women of childbearing age).
Although only small amounts of the medicine pass into breast milk, it is recommended not to take ibuprofen for prolonged periods during breastfeeding.
Driving and using machines
If you experience dizziness, vertigo, vision changes, or other symptoms while taking this medicine, do not drive or use hazardous machinery. If you only take one dose of ibuprofen or for a short period, it is not necessary to take special precautions.
Ibuprofen may delay your reaction time, which should be taken into account before performing activities that require greater vigilance, such as driving and using machinery. This applies to a greater extent to the combination with alcohol.
Geloprofen contains lactose and sodium.
This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; that is, it is
essentially "sodium-free".
Follow the administration instructions of this medication contained in this prospectus or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.
This medication is administered orally.
Only for occasional use and during limited periods.
The lowest effective dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult your doctor without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Patients with stomach discomfort should take the medication with milk or during meals. The tablets should be swallowed whole, with a glass of water, without chewing, breaking, crushing, or sucking to avoid discomfort in the mouth and throat irritation.
The recommended dose is:
Adults and adolescents over 12 years old (over 40 kg in weight):take 1 tablet of 400 mg every 6-8 hours, if necessary. Do not take more than 3 tablets (1200 mg of ibuprofen) in 24 hours.
Elderly patients (>65 years):your doctor will indicate the dose to be taken, as you may need a reduction in the usual dose.
Patients with kidney, liver, or heart failure:your doctor will indicate the dose to be taken, as you may need a reduction in the usual dose.
If symptoms worsen, if fever persists for more than 3 days or pain for more than 5 days (3 days in adolescents), consult your doctor.
The administration of the medication is subject to the appearance of pain or fever. As they appear, the medication should be suspended.
If you think the action of this medication is too strong or too weak, inform your doctor or pharmacist.
Use in children and adolescents
The use of this medication is not recommended in children (under 12 years old) or adolescents with a weight of less than 40 kg.
If you take more Geloprofen than you should
If you have taken more medication than you should, or if a child has accidentally ingested the medication, consult your doctor or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount used, or go to the nearest hospital to find out about the risk and ask for advice on the measures to be taken.
Normally, symptoms of overdose occur 4 to 6 hours after taking ibuprofen.
Symptoms of overdose may include nausea, stomach pain, vomiting (which may contain bloody sputum), diarrhea, headache, rapid involuntary eye movements, ringing in the ears, and confusion. Agitation or disorientation may also occur. At high doses, intestinal bleeding, hypotension, metabolic acidosis, symptoms of drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), coma, weakness, and dizziness, blood in urine, low potassium levels in the blood, chills, and breathing problems have been reported. Additionally, the prothrombin time/INR may be prolonged, probably due to interference with the actions of circulating coagulation factors. In rare cases, there have been reports of increased blood plasma acidity (metabolic acidosis), decreased body temperature, altered kidney function, stomach and intestinal bleeding, coma, transient loss of breathing (apnea), central nervous system depression, and respiratory system depression. There have also been cases of cardiovascular toxicity (decreased blood pressure, decreased heart rate, and increased heart rate).
If a severe overdose occurs, kidney failure and liver damage may occur. In these cases, the doctor will take the necessary measures.
Exacerbation of asthma is possible in asthmatics.
If you forget to take Geloprofen
Do not take a double dose to make up for forgotten doses.
If you forget to take your corresponding dose, take it as soon as you remember. However, if the time of the next dose is near, skip the forgotten dose and take the next dose at the usual time.
If you interrupt treatment with Geloprofen
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause adverse effects, although not all people suffer from them.
The incidence of adverse effects is lower in short treatments and if the daily dose is below the maximum recommended dose.
The frequencies shown below refer to the short-term use of maximum daily doses of up to 1,200 mg of oral ibuprofen:
anaphylactic reaction (in case of severe generalized hypersensitivity reaction, facial swelling, tongue, and larynx, dyspnea, tachycardia, hypotension, anaphylaxis, or severe shock may occur), aseptic meningitis (inflammation of the meninges, which are the membranes that protect the brain and spinal cord, not caused by bacteria). In most cases where aseptic meningitis has been reported with ibuprofen, the patient suffered from some form of autoimmune disease (such as systemic lupus erythematosus and other collagen diseases), which was a risk factor. The symptoms of aseptic meningitis observed were neck stiffness, headache, nausea, vomiting, fever, or disorientation. Other adverse effects are decreased platelets, decreased white blood cells (may manifest as frequent infections with fever, chills, or sore throat), decreased red blood cells (may manifest as difficulty breathing and pale skin), neutropenia (decreased neutrophils), and agranulocytosis (very large decrease in neutrophils), aplastic anemia (bone marrow failure to produce different types of cells), hemolytic anemia (premature destruction of red blood cells). The first symptoms are: fever, sore throat, superficial ulcers in the mouth, pseudogripal symptoms, extreme fatigue, bleeding, and bruises of unknown cause.
Exacerbation of inflammation-related infections has been observed with the use of NSAIDs. If signs of infection or worsening occur during the use of ibuprofen, it is recommended to consult a doctor as soon as possible.
A severe skin reaction known as DRESS syndrome (by its English acronym) may occur. The symptoms of DRESS syndrome include: skin rash, lymph node inflammation, and elevated eosinophils (a type of white blood cell).
Generalized red scaly rash, with bumps under the skin and blisters, accompanied by fever. The symptoms usually appear at the start of treatment (acute generalized exanthematous pustulosis). Stop taking this medication if you experience these symptoms and seek medical attention immediately. See also section 2.
The skin becomes sensitive to light.
Chest pain, which can be a sign of a potentially severe allergic reaction called Kounis syndrome.
If any of the following adverse effects occur, interrupt treatment andgo to your doctor immediately:
Reporting adverse effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not store at a temperature above 30 ºC.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need in the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Geloprofen composition
Core of the tablet: sodium croscarmellose, hypromellose, lactose, microcrystalline cellulose, cornstarch, colloidal anhydrous silica, magnesium stearate, and purified water.
Coating: hypromellose, titanium dioxide (E-171), purified talc, purified water, and propylene glycol (E-1520).
Appearance of Geloprofen and package contents
Oblong, biconvex tablets, scored on both sides, and white in color. They are presented in packs of 12 or 20 tablets in aluminum-PVC/PVDC blisters.
Only some package sizes may be marketed.
Marketing authorization holder
Ferrer Internacional, S.A.
Gran Vía Carlos III, 94
08028 – Barcelona (Spain)
Manufacturer
FARMALIDER, S.A.
C/ Aragoneses, 2
28108 Alcobendas – Madrid (Spain)
Date of last revision of this prospectus:November 2024
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)
http://www.aemps.gob.es/